Grantham, Mayo, Van Otterloo & Co (GMO)’s Enact Holdings ACT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,490
Closed -$416K 631
2025
Q4
$416K Sell
10,490
-1,803
-15% -$67.9K ﹤0.01% 592
2025
Q3
$471K Sell
12,293
-8,005
-39% -$297K ﹤0.01% 533
2025
Q2
$754K Buy
20,298
+4,483
+28% +$159K ﹤0.01% 502
2025
Q1
$550K Buy
15,815
+7,144
+82% +$239K ﹤0.01% 541
2024
Q4
$281K Sell
8,671
-287
-3% -$9.93K ﹤0.01% 539
2024
Q3
$325K Hold
8,958
﹤0.01% 519
2024
Q2
$275K Buy
+8,958
New +$273K ﹤0.01% 488

Other funds holding ACT

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACT Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Enact Holdings (ACT) in Q1 2026, closing a stake of 10,490 shares — an estimated $416K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACT in Q2 2024 and held it in 7 quarters. The position peaked at $754K in Q2 2025. 251 funds tracked by Wall St. Rank hold ACT as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Enact Holdings position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,490 Enact Holdings shares in Q1 2026, an estimated $416K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Enact Holdings in Q2 2024 and held it in 7 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Enact Holdings position peaked at $754K in Q2 2025.
  • 251 funds tracked by Wall St. Rank held Enact Holdings as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.